Inventor
ARRHENIUS THOMAS
US15 patents
⚠️ This page may combine multiple inventors who share the name “ARRHENIUS THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHUGAI PHARMACEUTICAL CO LTD
11 patentsUS7449482B2Nov 11, 2008
Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors
CHUGAI PHARMACEUTICAL CO LTD25 citations91
US7026491B2Apr 11, 2006
Coumarin derivatives useful as TNFα inhibitors
CHUGAI PHARMACEUTICAL CO LTD6 citations72
US7385063B2Jun 10, 2008
Method for preparing imidazole derivatives
CHUGAI PHARMACEUTICAL CO LTD5 citations59
US7524969B2Apr 28, 2009
Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
CHUGAI PHARMACEUTICAL CO LTD3 citations58
US7994318B2Aug 9, 2011
Coumarin derivatives useful as TNFα inhibitors
CHUGAI PHARMACEUTICAL CO LTD0 citations51
US7872142B2Jan 18, 2011
Coumarin derivatives useful as TNFα inhibitors
CHUGAI PHARMACEUTICAL CO LTD0 citations51
US7786145B2Aug 31, 2010
Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors
CHUGAI PHARMACEUTICAL CO LTD0 citations51
US7709510B2May 4, 2010
Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
CHUGAI PHARMACEUTICAL CO LTD0 citations51
US7709664B2May 4, 2010
Coumarin derivatives useful as TNFα inhibitors
CHUGAI PHARMACEUTICAL CO LTD0 citations51
US7723366B2May 25, 2010
Azole compounds as malonyl-CoA decarboxylase inhibitors for treating metabolic diseases
CHUGAI PHARMACEUTICAL CO LTD0 citations49
US7279477B2Oct 9, 2007
Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
CHUGAI PHARMACEUTICAL CO LTD0 citations40